Lataa...
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
In recent years, the metabotropic glutamate (mGlu) receptors have emerged as potential new drug targets for treatment of a range of CNS disorders. Some of the most compelling advances have been made in targeting specific mGlu receptor subtypes as a fundamentally new approach to the treatment of schi...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2907735/ https://ncbi.nlm.nih.gov/pubmed/19058862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2008.10.006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|